Fact CheckerSign in

NCT03876912RecruitingPhase 2

The effect of androgen deprivation therapy on the expression of prostate specific membrane antigen (PSMA) in treatment naive metastatic prostate cancer

Source: EU CTIS (euclinicaltrials.eu) · Last updated 28 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

To demonstrate that PSMA-flare seen 2-3weeks after initiation of ADT at baseline is more common in bony lesions than in prostatic lesions

Status (registry)
Recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
35 (estimated)
First submitted
27 Jan 2025
Start date
15 Apr 2019
Lead sponsor
Turku University Hospital
NCT number
NCT03876912
EU CT number
2024-519516-14-01
EudraCT number
2018-004853-26

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 35
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous PC treatment

Other illness

  • Uncontrolled serious infection

Who the study is looking for

  • Age: 40 to 85 years old
  • Language spoken: Finnish and Swedish
  • Diagnosis: Histologically confirmed adenocarcinoma of prostate
  • Adequate histological sampling consisting of at least 3 biopsy samples from each lobe
  • No previous surgical, radiation or endocrine treatment for prostate carcinoma
  • Clinical stage: T1c-T4NanyM1
  • Serum creatinine ≤ 1,5 x ULN
  • Mental status: Patients must be able to understand the meaning of the study
  • Informed consent: The patient must sign the appropriate Ethical Committee approved informed consent documents in the presence of the designated staff

Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Turku University Hospital
Coordinator of this site? Confirm its status
TurkuFinlandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.